ICH E6(R3) for small sponsors: key dates and what to do first

ICH E6 is the international good clinical practice (GCP) standard for the ethical, scientific and quality conduct of clinical trials with human participants, as described on ICH’s efficacy guidelines page. Its third revision, E6(R3), changes how sponsors are expected to think about quality, and it arrived in stages. This guide sets out the verified dates and the practical first steps for smaller teams.

The timeline

ICH has consolidated the Principles, Annex 1 and Annex 2 into one guideline. It is also offering Annex 2 as a standalone document through the end of 2026 to help teams find the new content.

What changed in spirit

According to ICH, the Principles and Annex 1 introduce “a flexible, risk-based framework for interventional clinical trials.” ICH’s Step 4 presentation describes the revision as grounded in quality by design, and it notes that the academic community had raised concerns about a lack of proportionality in the previous version.

Annex 2 adds GCP considerations for decentralized elements, pragmatic elements and the use of real-world data.

For a small sponsor, the practical message is that oversight should match the risk. You are expected to decide what is critical to quality in your trial and focus effort there, rather than applying the same intensity to everything.

First steps for a small team

1. Name your critical-to-quality factors. For each study, write down the few things that most affect participant safety and the reliability of the results, such as eligibility, primary endpoint assessments and safety reporting.
2. Tie your plan to those factors. Make sure your monitoring plan, data review and vendor oversight put the most attention on them.
3. Check your vendor oversight. If a CRO or other vendor does work for you, the sponsor still keeps oversight responsibility. Confirm you can see the information you need to exercise it.
4. Review decentralized and real-world-data elements against Annex 2. If your trial uses remote visits, home health, local labs or real-world data, map those elements before Annex 2 takes effect in your region.
5. Update SOPs and training. Record what changed and when your team was trained.

Check the effective date with each regulator where you run trials. The EU dates above come from EMA; other regions set their own timelines.

Where Protocol AI fits

Protocol AI turns your protocol into a draft study plan, with each item linked to its protocol section, so your team can see where the critical-to-quality factors sit and who owns each task. Your team reviews and approves every item.

Related: protocol deviations guide and CTMS buyer’s guide.

Last reviewed November 4, 2026. General information, not legal or regulatory advice.